Catalyst Wire Dossier Catalyst Wire Dossier

LUM001

· Mirum Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for LUM001, covering 2015-12-07 to 2021-11-19. Get the full timeline:

Most recent: Clinical Trial Update: An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Subjects With Alagille Syndrome (ALGS) [Phase 2]

See pricing